RAAB MICHAEL — SEC Form 4 filings
SEC reporting owner CIK 1321402. 49 Form 4 filings on record with FilingPulse; latest filed 2026-08-25.
Transaction summary — filings shown
Covers all 49 filings on record, filed 2024-01-18 to 2026-08-25. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 50 legs across 40 filings — 1,154,897 shares, $6,521,311 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 58.
- Largest priced transaction: sale of 45,687 shares @ $5.93 ($271,002) in ARDELYX, INC., filed 2025-08-25.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| ARDELYX, INC. (ARDX) | President & CEO, Director | 43 | — | 50 legs · 1,154,897 sh · $6,521,311 | 40 |
| AMICUS THERAPEUTICS, INC. (FOLD) | Director | 4 | — | — | 16 |
| Tempest Therapeutics, Inc. (TPST) | Director | 2 | — | — | 2 |
Form 4 filings — RAAB MICHAEL
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-25 | 4 | ARDELYX, INC. (ARDX) | Sale (S): 15,009 @ $3.86 · Sale (S): 15,976 @ $3.86 · Sale (S): 8,411 @ $3.86 · Sale (S): 19,178 @ $3.86 | EDGAR |
| 2026-07-17 | 4 | ARDELYX, INC. (ARDX) | Option exercise (M): 20,834 @ $0.99 · Sale (S): 41,668 @ $5.06 · Option exercise (M): 20,834 (derivative) @ $0 | EDGAR |
| 2026-06-17 | 4 | ARDELYX, INC. (ARDX) | Option exercise (M): 20,833 @ $0.99 · Sale (S): 41,666 @ $5.67 · Option exercise (M): 20,833 (derivative) @ $0 | EDGAR |
| 2026-05-22 | 4 | ARDELYX, INC. (ARDX) | Sale (S): 14,933 @ $6.27 · Sale (S): 7,861 @ $6.27 · Sale (S): 17,926 @ $6.27 · Sale (S): 14,028 @ $6.27 | EDGAR |
| 2026-05-19 | 4 | ARDELYX, INC. (ARDX) | Option exercise (M): 20,833 @ $0.99 · Sale (S): 41,666 @ $6.28 · Option exercise (M): 20,833 (derivative) @ $0 | EDGAR |
| 2026-04-27 | 4 | AMICUS THERAPEUTICS, INC. (FOLD) | Disposition to issuer (D): 115,857 @ $14.50 · Disposition to issuer (D): 20,000 (derivative) · Disposition to issuer (D): 16,236 (derivative) · Disposition to issuer (D): 19,473 (derivative) · Disposition to issuer (D): 18,574 (derivative) · Disposition to issuer (D): 36,111 (derivative) · +4 more | EDGAR |
| 2026-04-17 | 4 | ARDELYX, INC. (ARDX) | Option exercise (M): 20,834 @ $0.99 · Sale (S): 41,668 @ $6.29 · Option exercise (M): 20,834 (derivative) @ $0 | EDGAR |
| 2026-03-18 | 4 | ARDELYX, INC. (ARDX) | Option exercise (M): 20,833 @ $0.99 · Sale (S): 41,666 @ $5.84 · Option exercise (M): 20,833 (derivative) @ $0 | EDGAR |
| 2026-02-25 | 4 | ARDELYX, INC. (ARDX) | Option exercise (M): 20,833 @ $0.99 · Sale (S): 41,666 @ $6.25 · Option exercise (M): 20,833 (derivative) @ $0 | EDGAR |
| 2026-02-23 | 4 | ARDELYX, INC. (ARDX) | Sale (S): 40,401 @ $5.87 · Sale (S): 5,576 @ $5.71 · Sale (S): 2 @ $5.70 · Sale (S): 1 @ $5.70 · Sale (S): 2 @ $5.70 | EDGAR |
| 2026-01-28 | 4 | Tempest Therapeutics, Inc. (TPST) | Grant/award (A): 1,230 (derivative) @ $0 | EDGAR |
| 2026-01-26 | 4 | ARDELYX, INC. (ARDX) | Grant/award (A): 446,220 @ $0 · Grant/award (A): 669,330 (derivative) @ $0 | EDGAR |
| 2025-11-25 | 4 | ARDELYX, INC. (ARDX) | Sale (S): 46,887 @ $5.54 | EDGAR |
| 2025-08-25 | 4 | ARDELYX, INC. (ARDX) | Sale (S): 45,687 @ $5.93 | EDGAR |
| 2025-06-06 | 4 | AMICUS THERAPEUTICS, INC. (FOLD) | Grant/award (A): 20,414 @ $0 · Grant/award (A): 74,872 (derivative) @ $0 | EDGAR |
| 2025-05-22 | 4 | ARDELYX, INC. (ARDX) | Sale (S): 46,817 @ $4.08 | EDGAR |
| 2025-05-05 | 4 | ARDELYX, INC. (ARDX) | Option exercise (M): 20,833 @ $0.99 · Sale (S): 41,666 @ $4.25 · Option exercise (M): 20,833 (derivative) @ $0 | EDGAR |
| 2025-04-08 | 4 | ARDELYX, INC. (ARDX) | Option exercise (M): 20,833 @ $0.99 · Sale (S): 41,666 @ $4.59 · Option exercise (M): 20,833 (derivative) @ $0 | EDGAR |
| 2025-03-07 | 4 | ARDELYX, INC. (ARDX) | Option exercise (M): 20,834 @ $0.99 · Sale (S): 41,668 @ $5.36 · Option exercise (M): 20,834 (derivative) @ $0 | EDGAR |
| 2025-02-27 | 4 | ARDELYX, INC. (ARDX) | Grant/award (A): 570,217 @ $0 · Grant/award (A): 855,326 (derivative) @ $0 | EDGAR |
| 2025-02-21 | 4 | ARDELYX, INC. (ARDX) | Sale (S): 22,964 @ $5.62 | EDGAR |
| 2025-01-31 | 4 | ARDELYX, INC. (ARDX) | Option exercise (M): 20,833 @ $0.99 · Sale (S): 41,666 @ $5.36 · Option exercise (M): 20,833 (derivative) @ $0 | EDGAR |
| 2025-01-10 | 4 | ARDELYX, INC. (ARDX) | Option exercise (M): 20,833 @ $0.99 · Sale (S): 41,666 @ $5.31 · Option exercise (M): 20,833 (derivative) @ $0 | EDGAR |
| 2024-12-12 | 4 | ARDELYX, INC. (ARDX) | Option exercise (M): 25,000 @ $0.99 · Sale (S): 25,000 @ $5.26 · Option exercise (M): 25,000 (derivative) @ $0 | EDGAR |
| 2024-11-27 | 4 | ARDELYX, INC. (ARDX) | Sale (S): 25,000 @ $5.38 | EDGAR |
| 2024-11-22 | 4 | ARDELYX, INC. (ARDX) | Sale (S): 31,980 @ $4.79 | EDGAR |
| 2024-11-12 | 4 | ARDELYX, INC. (ARDX) | Sale (S): 2,743 @ $4.90 | EDGAR |
| 2024-10-31 | 4 | ARDELYX, INC. (ARDX) | Option exercise (M): 25,000 @ $0.99 · Sale (S): 25,000 @ $5.91 · Option exercise (M): 25,000 (derivative) @ $0 | EDGAR |
| 2024-10-15 | 4 | ARDELYX, INC. (ARDX) | Sale (S): 7,500 @ $6.01 | EDGAR |
| 2024-09-27 | 4 | ARDELYX, INC. (ARDX) | Sale (S): 3,000 @ $6.07 | EDGAR |
| 2024-09-13 | 4 | ARDELYX, INC. (ARDX) | Option exercise (M): 35,000 @ $0.99 · Sale (S): 35,000 @ $5.61 · Option exercise (M): 35,000 (derivative) @ $0 | EDGAR |
| 2024-08-28 | 4 | ARDELYX, INC. (ARDX) | Sale (S): 7,500 @ $6.22 | EDGAR |
| 2024-08-22 | 4 | ARDELYX, INC. (ARDX) | Sale (S): 32,225 @ $5.86 | EDGAR |
| 2024-08-14 | 4 | ARDELYX, INC. (ARDX) | Sale (S): 1,229 @ $5.71 | EDGAR |
| 2024-07-31 | 4 | ARDELYX, INC. (ARDX) | Option exercise (M): 30,000 @ $0.99 · Sale (S): 30,000 @ $5.64 · Option exercise (M): 30,000 (derivative) @ $0 | EDGAR |
| 2024-07-17 | 4 | ARDELYX, INC. (ARDX) | Sale (S): 7,500 @ $5.97 | EDGAR |
| 2024-06-28 | 4 | ARDELYX, INC. (ARDX) | Sale (S): 2,310 @ $6.59 | EDGAR |
| 2024-06-17 | 4 | ARDELYX, INC. (ARDX) | Option exercise (M): 35,000 @ $0.99 · Sale (S): 35,000 @ $6.65 · Option exercise (M): 35,000 (derivative) @ $0 | EDGAR |
| 2024-06-14 | 4 | Tempest Therapeutics, Inc. (TPST) | Grant/award (A): 16,000 (derivative) @ $0 | EDGAR |
| 2024-06-07 | 4 | AMICUS THERAPEUTICS, INC. (FOLD) | Grant/award (A): 11,847 @ $0 · Grant/award (A): 42,467 (derivative) @ $0 | EDGAR |
| 2024-05-31 | 4 | ARDELYX, INC. (ARDX) | Sale (S): 7,500 @ $6.72 | EDGAR |
| 2024-05-23 | 4 | ARDELYX, INC. (ARDX) | Sale (S): 31,484 @ $7.81 | EDGAR |
| 2024-05-15 | 4 | ARDELYX, INC. (ARDX) | Sale (S): 3,000 @ $7.99 | EDGAR |
| 2024-05-01 | 4 | ARDELYX, INC. (ARDX) | Option exercise (M): 30,000 @ $0.99 · Sale (S): 30,000 @ $6.40 · Option exercise (M): 30,000 (derivative) @ $0 | EDGAR |
| 2024-04-17 | 4 | ARDELYX, INC. (ARDX) | Sale (S): 7,500 @ $7.06 | EDGAR |
| 2024-04-02 | 4 | ARDELYX, INC. (ARDX) | Sale (S): 1,518 @ $7.31 | EDGAR |
| 2024-03-06 | 4 | AMICUS THERAPEUTICS, INC. (FOLD) | Option exercise (M): 15,000 @ $2.80 · Option exercise (M): 15,000 (derivative) @ $0 | EDGAR |
| 2024-02-22 | 4 | ARDELYX, INC. (ARDX) | Sale (S): 22,917 @ $8.75 | EDGAR |
| 2024-01-18 | 4 | ARDELYX, INC. (ARDX) | Grant/award (A): 475,000 @ $0 · Grant/award (A): 605,904 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1321402 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →